CARLI FOCHT: Open Payments
NPI 1548942212 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,804 in 159 payments from 21 companies in 2025. Trend: 2023 $943 · 2024 $3,801 · 2025 $2,804
Food & beverage: $2,804
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $710 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $377 |
| Neurocrine BioSciences, Inc. | 14 | $330 |
| Almatica Pharma LLC | 12 | $196 |
| Otsuka America Pharmaceutical, Inc. | 11 | $178 |
| Supernus Pharmaceuticals, Inc. | 14 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $157 |
| Axsome Therapeutics, Inc. | 11 | $153 |
| Lundbeck LLC | 4 | $88 |
| Alkermes, Inc. | 3 | $74 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, REXULTI, LOREEV XR, Qelbree, TRINTELLIX, Auvelity.
Industry payments across NC — which companies pay providers there.
